Evidence Hub

Primary Sclerosing Cholangitis Recurrence After Liver Transplantation: A Systematic Review and Updated Meta-Analysis

Vitor IC, Tomé MR, Amador WFO, Silveira IB, Leite MABC, Passos PRC, Filho VOC, Noronha MM et al.

Liver international : official journal of the International Association for the Study of the Liver, 2026

4,682 participants

Abstract

Background and aims: Primary sclerosing cholangitis (PSC) is an immune-mediated cholestatic liver disease. Liver transplantation (LT) remains the only definitive treatment for patients with advanced disease. However, recurrence of PSC (rPSC) after LT is still a significant clinical challenge. The aim of this study was to assess the prevalence and incidence of rPSC following transplantation and to identify factors associated with its occurrence.

Methods: We conducted a systematic review and meta-analysis of observational cohorts by searching PubMed, Embase and Cochrane for studies. Statistical analyses were conducted using R, applying a random-effects model with 95% confidence intervals.

Results: Twenty-nine studies were included, comprising 4682 patients who underwent LT for PSC (63.7% male). Most data originated from Europe (51.7%) and North America (29.2%), with additional cohorts from Asia (13.7%), South America (2.8%) and Oceania (2.6%). The worldwide pooled prevalence of rPSC was 18.66% (95% CI 15.33-22.52; I2 = 84%) between 1980 and 2024. As for the worldwide pooled incidence, rPSC occurred at 26.04 per 1000 person-years (95% CI 19.30-32.78; I2 = 76.1%). The continent with the highest rPSC prevalence was Oceania with 30.65% (95% CI 23.17-39.29; I2 = 13.8%) and South America had the highest incidence with 39.97 per 1000 person-years (95% CI 25.42-54.51). Younger recipient age (mean difference [MD] = 5.16 years, 95% CI 4.13-6.19; I2 = 51.3%), male sex (risk ratio [RR] =…

How strong is the evidence?

Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 4,682 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free